| Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease L Peyrin-Biroulet, M Ferrante, F Magro, S Campbell, D Franchimont, ... Journal of Crohn's and Colitis 5 (5), 477-483, 2011 | 333 | 2011 |
| Infliximab reduces endoscopic, but not clinical, recurrence of Crohn’s disease after ileocolonic resection M Regueiro, BG Feagan, B Zou, J Johanns, MA Blank, M Chevrier, ... Gastroenterology 150 (7), 1568-1578, 2016 | 330 | 2016 |
| Ciclosporin use in acute ulcerative colitis: a long-term experience S Campbell, S Travis, D Jewell European journal of gastroenterology & hepatology 17 (1), 79-84, 2005 | 242 | 2005 |
| Integrin αvβ8-mediated TGF-β activation by effector regulatory T cells is essential for suppression of T-cell-mediated inflammation JJ Worthington, A Kelly, C Smedley, D Bauché, S Campbell, JC Marie, ... Immunity 42 (5), 903-915, 2015 | 207 | 2015 |
| Successful infliximab treatment for steroid-refractory celiac disease: a case report HR Gillett, IDR Arnott, M McIntyre, S Campbell, A Dahele, M Priest, ... Gastroenterology 122 (3), 800-805, 2002 | 173 | 2002 |
| Clinical guidelines for the management of pouchitis DS Pardi, G D'Haens, B Shen, S Campbell, P Gionchetti Inflammatory bowel diseases 15 (9), 1424-1431, 2009 | 165 | 2009 |
| An exploration of the follow-up up needs of patients with inflammatory bowel disease K Kemp, J Griffiths, S Campbell, K Lovell Journal of Crohn's and Colitis 7 (9), e386-e395, 2013 | 142 | 2013 |
| Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients DW Owens, NJ Wilson, AJM Hill, EL Rugg, RM Porter, AM Hutcheson, ... Journal of cell science 117 (10), 1989-1999, 2004 | 112 | 2004 |
| Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial C Mowat, I Arnott, A Cahill, M Smith, T Ahmad, S Subramanian, S Travis, ... The lancet Gastroenterology & hepatology 1 (4), 273-282, 2016 | 111 | 2016 |
| Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection S Campbell, S Ghosh European journal of gastroenterology & hepatology 13 (2), 191-192, 2001 | 99 | 2001 |
| Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low‐dose azathioprine S Campbell, K Kingstone, S Ghosh Alimentary pharmacology & therapeutics 16 (3), 389-398, 2002 | 93 | 2002 |
| Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn’s disease? M Bhalme, A Sharma, R Keld, R Willert, S Campbell European journal of gastroenterology & hepatology 25 (5), 543-549, 2013 | 82 | 2013 |
| Inflammatory cues enhance TGFβ activation by distinct subsets of human intestinal dendritic cells via integrin αvβ8 TM Fenton, A Kelly, EE Shuttleworth, C Smedley, A Atakilit, F Powrie, ... Mucosal immunology 10 (3), 624-634, 2017 | 70 | 2017 |
| Scientific Committee of the European Crohn’s and Colitis Organization L Peyrin-Biroulet, M Ferrante, F Magro, S Campbell, D Franchimont, ... Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal …, 2011 | 64 | 2011 |
| Effective maintenance of inflammatory bowel disease remission by azathioprine does not require concurrent 5-aminosalicylate therapy S Campbell, S Ghosh European journal of gastroenterology & hepatology 13 (11), 1297-1301, 2001 | 60 | 2001 |
| Intussusception caused by a heterotopic pancreas. Case report and literature review N Chandra, S Campbell, M Gibson, H Reece-Smith, A Mee JOP 5 (6), 476-9, 2004 | 55 | 2004 |
| Assessing quality of life in Crohn’s disease: development and validation of the Crohn’s Life Impact Questionnaire (CLIQ) J Wilburn, SP McKenna, J Twiss, K Kemp, S Campbell Quality of Life Research 24, 2279-2288, 2015 | 54 | 2015 |
| Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England EA Russo, AW Harris, S Campbell, J Lindsay, A Hart, N Arebi, A Milestone, ... Alimentary pharmacology & therapeutics 29 (3), 308-314, 2009 | 54 | 2009 |
| Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long‐term extension data from a Phase 3 study C Schmidt, T Ahmad, Z Tulassay, DC Baumgart, B Bokemeyer, S Howaldt, ... Alimentary pharmacology & therapeutics 44 (3), 259-270, 2016 | 53 | 2016 |
| Replication and Meta‐Analysis of 13,000 Cases Defines the Risk for Interleukin‐23 Receptor and Autophagy‐Related 16‐Like 1 Variants in Crohn’s Disease L Cotterill, D Payne, S Levison, J McLaughlin, E Wesley, M Feeney, ... Canadian Journal of Gastroenterology and Hepatology 24 (5), 297-302, 2010 | 47 | 2010 |
